Interaction between lung cancer and tuberculosis in disease development and progression
Lung cancer is the primary cause of cancer-related mortality in China,a nation with a notably high prevalence of Mycobacterium tuberculosis(MTB)infection.Consequently,a significant population suffers from concurrent tuberculosis and lung cancer.MTB infection reshapes the host immune system,fostering a microenvironment conducive to the initiation and progression of lung cancer.Current monotherapies targeting either pulmonary tuberculosis or lung cancer exhibit limited effectiveness in managing patients with both conditions and may even lead to mutual interference.This review synthesizes evidence from PubMed and Chinese databases,offering an in-depth analysis of the mechanisms by which MTB infection facilitates lung cancer development and progression.Furthermore,it examines the overlapping clinical manifestations of these diseases,which complicate accurate diagnosis,and discusses potential strategies for integrated treatment.